Cariprazine as a maintenance therapy in the prevention of mood episodes in adults with bipolar I disorder.

Roger S McIntyreBethany DavisJane RodgersLudmyla RekedaJulie AdamsLakshmi N Yatham

Published in: Bipolar disorders (2024)

Cariprazine was not superior to placebo in the prevention of relapses in this study. Relapse rates were unusually low in the placebo group. Cariprazine was well-tolerated.

Keyphrases

bipolar disorder
double blind
phase iii
randomized controlled trial
stem cells
bone marrow
depressive symptoms
free survival
cell therapy